By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.




CEO: Pascal Soriot

CFO: Marc Dunoyer

CMO: Marc Dunoyer

CTO: Andrew Chen

CCO: Katarina Ageborg

CMO: Sean Bohen


Please click here for clinical trial information.


Please click here for AstraZeneca job opportunities.


AstraZeneca Medications

For more information, visit and follow us on


Key Statistics

Ownership: Public

Web Site: AstraZeneca PLC
Employees: 50,000 worldwide
Symbol: AZN

Company News
AstraZeneca PLC (AZN) Release: TAGRISSO (Osimertinib) Demonstrates Superiority Over Chemotherapy In EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer 12/6/2016 12:36:55 PM
AstraZeneca PLC (AZN) Release: Early Data Demonstrate Clinical Activity Of Acalabrutinib In Difficult-to-Treat Chronic Lymphocytic Leukemia 12/6/2016 12:24:07 PM
AstraZeneca PLC (AZN) Release: Early Data Demonstrate Clinical Activity Of Acalabrutinib In Difficult-To-Treat Chronic Lymphocytic Leukemia 12/5/2016 11:17:53 AM
AstraZeneca PLC (AZN) to Shift an Unknown Number of Jobs to Other Countries in Cost-Cutting Move 12/5/2016 7:17:37 AM
Tiny Bicycle Therapeutics Snags a Drug Discovery Pact Worth $1 Billion With AstraZeneca PLC (AZN) 12/1/2016 5:54:07 AM
Cytel And AstraZeneca PLC (AZN) Early Clinical Development Software Collaboration Facilitates Clinical Development Decision-Making 11/29/2016 10:46:08 AM
AstraZeneca PLC (AZN) Eyes Local Prospects 11/29/2016 7:40:11 AM
AstraZeneca PLC (AZN) Catches a Break as the FDA Lifts Hold on Head And Neck Cancer Trials 11/22/2016 5:26:28 AM
AstraZeneca PLC (AZN) Announces Study Results Show SYMBICORT Improves Lung Function In Pediatric Asthma Patients 11/11/2016 11:57:28 AM
AstraZeneca PLC (AZN) Faces Another R&D Setback as Plans to File for Early Approval for Cancer Med are Scrapped 11/10/2016 6:38:30 AM